Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 14 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

7 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
7(63.6%)
Phase 2
3(27.3%)
Phase 1
1(9.1%)
11Total
Phase 4(7)
Phase 2(3)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (14)

Showing 14 of 14 trials
NCT03857399Phase 2Completed

Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using Caspofungin

Role: lead

NCT02151240Phase 4Completed

Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection in Patients With Herpes Zoster

Role: lead

NCT04199559Phase 1Unknown

Evaluating Combination Therapy Using Autologous Dendritic Cells Pulsed With Antigen Peptides and Nivolumab for Subjects With Advanced Non-Small Cell Lung Cancer

Role: collaborator

NCT04106024Phase 2Unknown

Efficacy and Safety of Anlotinib in Patients With Advanced Gastrointestinal Stromal Tumor After Failure of Imatinib: a Prospective, Single Arm and Multicenter Trial

Role: lead

NCT03975036Phase 2Unknown

Clinical Study on the Second-line and Above Treatment of Advanced Solid Tumor With Anlotinib Combined With Pd-1 Antibody

Role: collaborator

NCT03940404Unknown

Anlotinib Therapy in Patients With Advanced Lung Cancer.

Role: collaborator

NCT03349008Phase 4Unknown

Magnesium Isoglycyrrhizinate Followed by Diammonium Glycyrrhizinate and Combined With Entecavir in Chronic Hepatitis B

Role: lead

NCT03308227Unknown

Plasma and Lung Tissue Concentrations of Linezolid in Septic Shock Patients

Role: collaborator

NCT03158246Phase 4Unknown

Generic Zoledronic Acid Versus Original Zoledronic Acid in Postmenopausal Osteoporotic Women

Role: lead

NCT03148704Unknown

Intensive Medicines Monitoring Project of Palonosetron Hydrochloride Capsules (Ruo Shan®)

Role: lead

NCT02317159Phase 4Unknown

Efficacy and Safety of Imatinib Mesylate as First-line Treatment for the Patients With Chronic Phase of Chronic Myeloid Leukemia

Role: lead

NCT02202473Phase 4Completed

Oxymatrine Plus Lamivudine Combination Therapy Versus Lamivudine Monotherapy for Chronic Hepatitis B Infected Subjects

Role: collaborator

NCT02013102Phase 4Unknown

A Phase Ⅳ Study of Decitabine in Myelodysplastic Syndrome

Role: lead

NCT01802996Phase 4Unknown

Evaluate the Efficacy of Magnesium Isoglycyrrhizinate in the Prevention of Chemotherapy Related Acute Liver Injury

Role: lead

All 14 trials loaded